Commodore Capital »

Vistagen Therapeutics Ord shares owned by Commodore Capital

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Commodore Capital from 13F filings

Historical chart of Commodore Capital investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Commodore Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.1M 1.6M 5.14
2023-09-30 $8.3M 1.6M 5.24

More positions owned by Commodore Capital

Merus N V (MRUS)
Xenon Pharmaceuticals (XENE)
Nuvalent Inc-a (NUVL)
Vera Therapeutics Cl A (VERA)
Rhythm Pharmaceuticals (RYTM)
Vaxcyte (PCVX)
Cabaletta Bio (CABA)
Immunovant (IMVT)
Miragen Therapeutics (VRDN)
Arvinas Ord (ARVN)
Spyre Therapeutics Com New (SYRE)
Enliven Therapeutics (ELVN)
Cogent Biosciences (COGT)
Alpine Immune Sciences (ALPN)
Soleno Therapeutics (SLNO)

View all positions for Commodore Capital

Top funds holding Vistagen Therapeutics Ord

BVF
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Nantahala Capital Management
Commodore Capital
Citadel Advisors
Sphera Funds Management
ADAR1 Capital Management
Two Sigma Investments
Goldman Sachs Group
BML Capital Management
Bank Of Montreal
William Blair $ Company
Gts Securities
Citigroup

View all funds holding Vistagen Therapeutics Ord